From the Brochure: http://www.biofinance.ca/DownloadourBrochures

"BioFinance 2006 is the life science industry’s leading investor conference in
Canada. The meeting brings together key industry players to consider investment opportunities and issues affecting companies in biotechnology, medical devices, drug delivery, diagnostics, medical systems and research tools. Participants include senior life science executives, institutional and venture investors, industry analysts, corporate finance executives and experts from the medical communities in Canada, the US and Europe. 866-342-4933
www.biofinance.ca

The Life Science sector is one of the most dynamic and innovative sectors of
our economy. In Canada, the top ten companies in this sector have a combined
market cap of $ 13.9 Billion Cdn. Equally important to the industry are the
number of biotech drug products and vaccines currently in late stage clinical trials. They promise to help fight against more than 200 diseases including various cancers, Alzheimer’s, cardiovascular, Multiple Sclerosis, HIV/AIDS, inflammation including arthritis, diabetes, chronic pain, neurological disorders, respiratory and immunology. They are also involved in genomics, medical devices, diagnostics, nanotechnology, research tools and
medical systems.

With more than 100 company presentations, BioFinance 2006 will showcase diverse life science companies, their contribution and the investment opportunities they represent.

BioFinance will feature CEO roundtables that address specific financing and management issues relevant to the industry."